background
investig
tempor
progress
clinic
radiolog
virolog
chang
commun
outbreak
sever
acut
respiratori
syndrom
sar
follow
patient
week
manag
standard
treatment
protocol
ribavirin
corticosteroid
assess
pattern
clinic
diseas
viral
load
risk
factor
poor
clinic
outcom
use
virolog
diagnost
method
find
fever
pneumonia
initi
improv
patient
develop
recurr
fever
mean
sd
day
wateri
diarrhoea
day
radiolog
worsen
day
respiratori
symptom
worsen
day
patient
improv
initi
pulmonari
lesion
associ
appear
new
radiolog
lesion
site
nine
patient
develop
spontan
pneumomediastinum
develop
acut
respiratori
distress
syndrom
ard
week
quantit
reversetranscriptas
rt
pcr
nasopharyng
aspir
patient
four
ard
show
peak
viral
load
day
day
load
lower
admiss
age
chronic
hepat
b
viru
infect
treat
lamivudin
independ
signific
risk
factor
progress
ard
sarsassoci
coronaviru
faec
seen
rtpcr
patient
day
mean
time
seroconvers
day
interpret
consist
clinic
progress
shift
radiolog
infiltr
invert
v
viralload
profil
suggest
worsen
week
unrel
uncontrol
viral
replic
may
relat
immunopatholog
damag
sever
acut
respiratori
syndrom
sar
new
emerg
diseas
affect
mani
countri
case
report
novel
viru
sarsassoci
coronaviru
identifi
causal
agent
clinic
radiolog
investig
find
initi
present
previous
describ
tempor
progress
unclear
rout
durat
viral
shed
best
clinic
sampl
diagnosi
differ
stage
ill
also
larg
unknown
march
major
outbreak
sar
involv
patient
occur
amoy
garden
highris
hous
estat
hong
kong
epidemiolog
investig
suggest
pointsourc
outbreak
link
faulti
sewag
system
initi
contamin
excreta
index
case
visit
hous
block
march
first
adult
patient
belong
household
admit
clinic
diagnosi
sar
one
hospit
prospect
studi
clinic
haematolog
radiolog
microbiolog
find
patient
period
day
correl
find
treatment
viral
load
nasopharyng
aspir
elucid
pathogenesi
impact
treatment
report
use
differ
clinic
sampl
virolog
diagnosi
import
transmiss
march
includ
patient
admit
unit
christian
hospit
amoy
garden
hous
estat
fulfil
modifi
definit
sar
briefli
case
definit
fever
higher
cough
short
breath
new
pulmonari
infiltr
chest
radiographi
highresolut
ct
absenc
altern
diagnosi
explain
clinic
present
patient
nurs
isol
ward
sar
patient
studi
approv
ethic
committe
unit
christian
hospit
hong
kong
enter
predesign
databas
daili
clinic
find
base
histori
physic
examin
oximetr
measur
haematolog
biochem
radiolog
microbiolog
investig
collect
nasopharyng
aspir
clot
blood
virolog
studi
patient
present
day
onset
ill
anteroposterior
chest
radiographi
done
daili
patient
chest
radiograph
jointli
report
specialist
radiologist
respiratori
physician
highresolut
ct
thorax
patient
appar
normal
equivoc
atyp
chest
radiograph
patient
develop
acut
respiratori
distress
syndrom
ard
partial
arteri
pressur
oxygen
pao
fraction
inspir
oxygen
fio
less
kpa
record
acut
physiolog
chronic
health
evalu
ii
apach
ii
score
patient
sarsassoci
coronaviru
rna
detect
reversetranscriptas
rt
pcr
initi
nasopharyng
aspir
sampl
collect
nasopharyng
aspir
urin
faecal
sampl
everi
day
patient
quantit
pcr
done
nasopharyng
aspir
collect
day
onset
symptom
nasopharyng
aspir
admiss
assess
rapid
immunofluoresc
antigen
detect
influenza
b
parainfluenza
type
respiratori
syncyti
viru
adenoviru
cultur
convent
respiratori
pathogen
mardin
darbi
canin
kidney
rde
fetal
rhesu
kidney
cell
line
rtpcr
sar
coronaviru
done
directli
clinic
sampl
briefli
total
rna
clinic
sampl
revers
transcrib
random
hexam
cdna
amplifi
primer
realtim
quantit
pcr
assay
cdna
amplifi
sybr
green
fluoresc
reaction
roch
mannheim
germani
describ
briefli
l
reaction
mixtur
contain
l
cdna
mmoll
magnesium
chlorid
moll
forward
revers
primer
reaction
mixtur
thermalcycl
light
cycler
roch
mannheim
min
follow
cycl
min
plasmid
target
sequenc
use
gener
standard
curv
end
assay
pcr
product
bp
subject
melt
curv
analysi
find
specif
assay
acut
convalesc
sera
test
parallel
sarsassoci
coronaviru
igg
sarsassociatedcoronavirusinfect
vero
cell
fix
aceton
indirect
immunofluoresc
format
investig
blood
sputum
endotrach
aspir
urin
bacteriolog
clinic
indic
patient
sepsi
work
admiss
fever
recur
stool
sent
routin
bacteriolog
cultur
clostridium
difficil
cytotoxin
assay
examin
parasit
select
patient
patient
treat
g
intraven
amoxicillinclavulan
everi
h
mg
oral
azithromycin
daili
patient
known
penicillin
allergi
administ
mg
oral
levofloxacin
everi
h
soon
diagnosi
sar
establish
mgkg
intraven
ribavirin
everi
h
day
tail
regimen
hydrocortison
start
dose
mg
intraven
everi
h
day
follow
oral
prednisolon
day
mgkg
day
mgkg
day
mgkg
day
given
use
puls
methylprednisolon
mg
intraven
daili
two
three
dose
patient
worsen
increas
short
breath
oxygen
desatur
radiolog
worsen
hbsagposit
patient
given
mg
oral
lamivudin
daili
take
corticosteroid
compar
risk
factor
associ
develop
ard
fisher
exact
test
categor
variabl
student
test
continu
variabl
signific
risk
factor
identifi
univari
analys
analys
multipl
logist
regress
identifi
independ
risk
factor
associ
develop
ard
took
p
signific
use
spss
version
analys
sponsor
studi
role
studi
design
data
collect
data
analysi
data
interpret
write
report
patient
ethnic
chines
remaind
filipino
maletofemal
ratio
one
mean
age
sd
year
five
patient
smoker
underli
diseas
identifi
patient
includ
nine
patient
posit
hbsag
stigmata
chronic
liver
diseas
normal
liver
function
test
clinic
symptom
admiss
includ
fever
patient
chill
rigor
myalgia
cough
sore
throat
eight
short
breath
three
headach
dizzi
three
diarrhoea
one
initi
chest
radiograph
abnorm
patient
involv
confin
one
lung
zone
multizon
lowerzon
infiltr
consolid
occur
patient
initi
highresolut
ct
done
patient
initi
chest
radiograph
normal
equivoc
atyp
patient
abnorm
confin
one
lobe
multilobar
involv
seen
patient
focal
groundglass
opacif
type
abnorm
eight
patient
patient
consolid
type
infiltr
haematolog
biochem
investig
anaemia
detect
six
leucopenia
five
sever
lymphopenia
less
l
thrombocytopenia
rais
valu
seen
alanin
aminotransferas
ul
aspart
aminotransferas
ul
creatinin
kinas
ul
patient
respect
median
lymphocyt
count
decreas
l
iqr
admiss
l
l
l
day
respect
term
diseas
progress
except
one
patient
becam
afebril
within
h
standard
treatment
protocol
fever
recur
patient
mean
day
sd
ten
patient
posit
find
sepsi
work
three
stenotrophomona
maltophilia
bacteraemia
four
clinic
evid
catheterrel
sepsi
three
nosocomi
pneumonia
due
klebsiella
pneumonia
two
escherichia
coli
one
septic
episod
respond
appropri
antimicrobi
treatment
remov
infect
cathet
remain
patient
fever
recur
mean
day
unlik
caus
hospitalacquir
infect
day
patient
develop
anoth
episod
fever
figur
wateri
diarrhoea
develop
patient
onset
mean
day
rate
diarrhoea
peak
mean
day
maximum
frequenc
time
daili
figur
work
diarrhoeal
pathogen
includ
c
difficil
cytotoxin
neg
patient
mean
durat
diarrhoea
day
simultan
occurr
fever
diarrhoea
occur
patient
concomit
fever
diarrhoea
radiolog
worsen
occur
patient
improv
diarrhoea
occur
patient
day
radiolog
worsen
note
patient
mean
day
develop
shift
radiolog
lesion
evidenc
improv
origin
lesion
follow
appear
new
lesion
figur
worsen
origin
lesion
without
concentr
gl
mean
sd
initi
total
peripher
white
blood
cell
count
l
mean
sd
initi
lymphocyt
count
l
mean
sd
initi
platelet
count
l
figur
patient
develop
arteri
oxygen
desatur
less
room
air
mean
day
onset
symptom
figur
patient
requir
intens
care
mean
day
among
intub
mean
day
patient
progress
ard
requir
mechan
ventil
day
mechan
ventil
ard
mean
pao
tofio
ratio
kpa
mean
apach
ii
score
time
occurr
ard
show
bimod
pattern
one
peak
day
anoth
peak
day
figur
seven
patient
develop
hospitalacquir
infect
stay
intensivecar
unit
includ
hospitalacquir
pneumonia
three
meticillinresist
staphylococcu
epidermidi
bacteraemia
one
clinic
sepsi
three
without
posit
cultur
univari
analysi
risk
factor
associ
ard
requir
ventilatori
support
intens
care
age
male
sex
chronic
hepat
b
viru
carriag
rais
creatinin
recurr
fever
tabl
lymphocyt
count
ard
patient
day
differ
significantli
nonard
patient
multivari
analysi
age
chronic
hepat
b
viru
infect
signific
risk
factor
tabl
mean
length
stay
patient
day
wherea
patient
develop
ard
mean
length
stay
day
time
write
five
patient
die
studi
period
two
age
year
succumb
acut
myocardi
infarct
day
respect
one
patient
die
clinic
sepsi
day
anoth
two
patient
die
clinic
sepsi
ard
day
respect
patient
discharg
home
transfer
rehabilit
facil
one
patient
transfer
specialis
obstetr
unit
urgent
deliveri
babi
week
gestat
patient
remain
hospit
treat
intens
care
ard
tabl
patient
initi
document
sarsassoci
coronaviru
rna
nasopharyng
aspir
rtpcr
serial
follow
sequenti
sampl
virolog
profil
shown
tabl
quantit
rtpcr
nasopharyng
aspir
show
invert
v
pattern
mean
geometr
viral
load
copi
per
ml
copi
per
ml
copi
per
ml
day
respect
onset
symptom
figur
studi
sar
gener
retrospect
limit
descript
initi
clinic
haematolog
radiolog
microbiolog
find
patient
studi
howev
resid
hous
estat
place
close
surveil
depart
health
soon
identif
outbreak
resid
underw
frequent
health
check
symptomat
patient
admit
hospit
soon
onset
symptom
thu
admit
earli
cours
ill
therefor
abl
prospect
studi
larg
cohort
patient
infect
one
commun
outbreak
sar
epidemiolog
link
virolog
confirm
sarsassoci
coronaviru
clinic
progress
sar
mostli
uniform
cohort
triphas
pattern
week
characteris
fever
myalgia
system
symptom
gener
improv
day
increas
viral
load
phase
suggest
symptom
larg
relat
effect
viral
replic
cytolysi
diseas
progress
week
patient
frequent
recurr
fever
onset
diarrhoea
oxygen
desatur
strikingli
nearli
half
patient
shift
radiograph
shadow
viralinduc
damag
primari
patholog
mechan
flit
pattern
radiolog
chang
difficult
explain
time
igg
seroconvers
start
day
seem
correl
fall
viral
load
occur
day
despit
use
puls
methylprednisolon
sever
clinic
worsen
also
occur
time
explain
uncontrol
viral
replic
find
support
progress
decreas
rate
viral
shed
nasopharynx
stool
urin
day
onset
symptom
patient
underw
prospect
followup
rtpcr
taken
togeth
find
suggest
lung
damag
phase
relat
immunopatholog
damag
result
overexuber
host
respons
rather
uncontrol
viral
replic
patient
cohort
progress
third
phase
characteris
ard
necessit
ventilatori
support
inevit
sever
patient
develop
nosocomi
sepsi
phase
endorgan
damag
sever
lymphopenia
term
pathogenesi
pulmonari
reoviru
infect
athym
mice
lower
plaqueform
valu
associ
patholog
chang
bronchiol
obliteran
organis
pneumonia
wherea
higher
inoculum
associ
ard
lessen
risk
progress
chronic
phase
ard
effect
antivir
reduc
viral
load
may
import
time
write
antivir
report
clinic
effect
treatment
novel
coronaviru
ribavirin
broadspectrum
antivir
activ
effect
treatment
fulmin
hepat
mice
caus
mous
hepat
coronaviru
although
inhibitori
activ
ribavirin
mous
hepat
coronaviru
weak
ribavirin
decreas
releas
proinflammatori
cytokin
macrophag
mice
also
switch
immun
respons
mice
respons
thu
irrespect
antivir
role
ribavirin
may
act
immunomodul
effect
antivir
agent
need
decreas
initi
cytolyt
damag
viral
load
first
phase
may
turn
result
decreas
immunopatholog
damag
second
phase
sinc
notabl
proport
patient
develop
ard
role
immunolog
direct
strategi
corticosteroid
intraven
immunoglobulin
igmenrich
immunoglobulin
convalesc
plasma
antitumour
necrosi
factor
thymosin
deserv
investig
unexpectedli
chronic
hepat
b
infect
import
independ
risk
factor
progress
ard
find
may
also
explain
higher
rate
death
among
young
chines
patient
high
rate
chronic
hepat
b
infect
southern
china
find
import
patient
lamivudin
given
prophylaxi
patient
take
corticosteroid
assess
viral
load
hepat
b
viru
dna
sinc
liver
function
test
normal
clinic
stigmata
chronic
liver
diseas
thu
patient
poor
case
definit
sar
clinic
rather
nonspecif
absenc
epidemiolog
histori
contact
show
igg
seroconvers
sensit
day
even
despit
corticosteroid
treatment
case
igg
isotypespecif
antibodi
sar
coronaviru
test
antibodi
immunoglobulin
class
assay
seroconvers
probabl
detect
earlier
although
viral
rna
detect
nasopharyng
aspir
sensit
present
test
multipl
nasopharyng
faecal
sampl
increas
sensit
rtpcr
assay
presenc
viru
stool
import
find
suggest
possibl
oralfaec
transmiss
epidemiolog
investig
amoy
garden
sar
outbreak
suggest
outbreak
caus
faulti
sewag
system
diarrhoea
seem
promin
cohort
patient
previous
report
sever
wateri
diarrhoea
patient
present
challeng
healthcar
worker
infect
control
whether
appar
chang
clinic
present
relat
differ
rout
infect
mutat
viru
still
conjectur
importantli
mortal
rate
report
higher
previous
report
figur
day
note
absenc
relat
high
rate
spontan
pneumomediastinum
unrel
intub
positivepressur
ventil
phenomenon
rare
report
advanc
cytomegaloviru
pneumonia
influenza
bronchiol
wherea
spontan
pneumothorax
commonli
report
pneumocysti
carinii
staphylococcu
aureu
pneumonia
initi
radiograph
lesion
sar
pleural
base
patient
initi
consolid
abut
mediastinum
adhes
cyst
format
might
occur
interfac
mediastin
pleura
pulmonari
pleura
ruptur
cyst
result
spontan
pneumomediastinum
altern
diffus
peripher
pneumon
chang
follow
pleural
adhes
may
occur
pariet
pleura
chest
wall
leav
mediastin
site
area
ruptur
cyst
occur
also
creat
necessari
set
spontan
pneumomediastinum
occur
without
spontan
pneumothorax
rtpcr
respiratori
faecal
sampl
togeth
serolog
confirm
diagnosi
sarsassoci
coronaviru
infect
sar
patient
progress
diseas
respiratori
failur
might
associ
uncontrol
viral
replic
may
fact
immunopatholog
natur
